Pathway analysis revealed two TME-derived growth factors, IGF1 (log2 fold change = 6.55) and EGF (log2 fold change = 5.24) that are driving Hif1α signaling within the HCC tumor cells (Figure 6). The gene discussed is HIF1A; the disease is neoplasm.